venlafaxine NDC 52427-632

NDC codes

FDA NDC Directory

Product NDC (as listed)52427-632Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52427-0632Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52427-632-30	52427063230	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (52427-632-30)Marketed from Aug 1, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): venlafaxine
Generic name (nonproprietary): venlafaxine
Active ingredients: Venlafaxine besylate monohydrate — 112.5 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Almatica Pharma LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 215429
Marketing start: Jun 30, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 52427-632_1b0762be-0db0-b997-b76b-b212a496f82cSPL ID 1b0762be-0db0-b997-b76b-b212a496f82cSPL set ID e81a2daf-b8b2-7c05-b532-bc775700b100RxCUI 2605950UNII 18XP3YT5NHUPC 0352427632303
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452427063230 followed by a unit qualifier and the quantity

Package 52427-0632-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 9, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Venlafaxine Extended-Release Tablets are indicated in adults for the treatment of: Major depressive disorder (MDD) Generalized Anxiety Disorder (GAD) Venlafaxine Extended-Release Tablets are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated in adults for the treatment of: Major Depressive Disorder (MDD) ( 1 ) Generalized Anxiety Disorder (GAD) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)